![Michael Milligan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Milligan
Director of Finance/CFO at
NEUMORA THERAPEUTICS, INC.
Net worth: 38 913 $ as of 2026-05-30
Profile
Michael Lee Milligan is currently Chief Financial Officer & Executive Vice President at New Haven Pharmaceuticals, Inc. and Chief Financial & Accounting Officer at Neumora Therapeutics, Inc. Former positions include Vice President Finance & Controller at Y-mAbs Therapeutics, Inc., Vice President-Finance & Controller at Acorda Therapeutics, Inc., and Chief Accounting Officer & Vice President at Shionogi, Inc. Education includes an MBA from Georgia State University and an undergraduate degree from the University of Miami.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-16 | 21,034 ( 0.01% ) | 38 913 $ | 2026-05-30 |
Michael Milligan active positions
| Companies | Position | Start |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Director of Finance/CFO | 2025-02-13 |
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Director of Finance/CFO | - |
Former positions of Michael Milligan
| Companies | Position | End |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - |
Shionogi, Inc.
 Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Comptroller/Controller/Auditor | - |
| YMAS THER | Comptroller/Controller/Auditor | - |
Training of Michael Milligan
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
9
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Acorda Therapeutics, Inc.
 Acorda Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops, manufactures and markets therapeutic products for neurological disorders | Health Technology |
Georgia State University
 Georgia State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Miami
 University of Miami Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new prescription drug products | Health Technology |
Shionogi, Inc.
Shionogi, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes antibiotics | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Neumora Therapeutics, Inc.
 Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
- Stock Market
- Insiders
- Michael Milligan
